Which pharmaceutical company was the first to launch an FDA-approved personalized medicine program that matched cancer treatments to patients based on genetic biomarkers?

Personalized medicine is revolutionizing healthcare by tailoring treatments to individual patient profiles. As medical technology advances, pharmaceutical companies are investing heavily in personalization strategies that consider genetic makeup, lifestyle factors, and specific biomarkers. This trivia question examines a groundbreaking retail personalization initiative that changed how medications are developed and marketed to healthcare providers and patients.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Genentech with Herceptin for HER2-positive breast cancer
Pfizer with Xalkori for ALK-positive lung cancer
Novartis with Gleevec for Philadelphia chromosome-positive leukemia
AstraZeneca with Tagrisso for EGFR-mutated lung cancer